Rafferty Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$506K Buy
+141,212
New +$561K ﹤0.01% 890
2025
Q2
Sell
-155,875
Closed -$1.04M 1100
2025
Q1
$1.04M Sell
155,875
-385
-0.2% -$3.8K ﹤0.01% 733
2024
Q4
$1.96M Buy
156,260
+27,534
+21% +$414K 0.01% 652
2024
Q3
$2.38M Buy
128,726
+11,081
+9% +$227K 0.01% 588
2024
Q2
$2.53M Sell
117,645
-211,398
-64% -$4.86M 0.01% 580
2024
Q1
$8.86M Buy
329,043
+120,538
+58% +$3.42M 0.03% 313
2023
Q4
$6.25M Sell
208,505
-33,137
-14% -$731K 0.03% 393
2023
Q3
$4.95M Buy
241,642
+8,558
+4% +$156K 0.03% 388
2023
Q2
$4.63M Sell
233,084
-66,375
-22% -$1.34M 0.03% 433
2023
Q1
$5.13M Buy
299,459
+5,498
+2% +$108K 0.03% 378
2022
Q4
$5.75M Buy
293,961
+67,443
+30% +$1.24M 0.05% 346
2022
Q3
$3.62M Buy
226,518
+139,896
+162% +$2.18M 0.04% 387
2022
Q2
$1.19M Sell
86,622
-78,651
-48% -$938K 0.01% 588
2022
Q1
$2.62M Buy
165,273
+20,866
+14% +$360K 0.02% 535
2021
Q4
$3.15M Buy
144,407
+56,213
+64% +$1.53M 0.02% 525
2021
Q3
$2.64M Buy
88,194
+31,707
+56% +$1.15M 0.02% 548
2021
Q2
$2.5M Sell
56,487
-5,646
-9% -$245K 0.02% 598
2021
Q1
$2.76M Buy
62,133
+55,163
+791% +$3.03M 0.02% 541
2020
Q4
$382K Sell
6,970
-29,852
-81% -$1.09M ﹤0.01% 748
2020
Q3
$842K Buy
36,822
+21,975
+148% +$541K 0.01% 599
2020
Q2
$311K Buy
+14,847
New +$268K ﹤0.01% 819
2020
Q1
Sell
-15,783
Closed -$359K 761
2019
Q4
$359K Sell
15,783
-25,198
-61% -$421K 0.01% 753
2019
Q3
$477K Sell
40,981
-3,734
-8% -$46.3K 0.01% 668
2019
Q2
$671K Buy
44,715
+13,792
+45% +$241K 0.01% 635
2019
Q1
$542K Buy
+30,923
New +$488K 0.01% 654

Other funds holding RCKT